BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
0.263
+0.003 (0.96%)
At close: Dec 19, 2024, 4:00 PM
0.305
+0.042 (16.15%)
Pre-market: Dec 20, 2024, 5:29 AM EST
BioNexus Gene Lab Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 19, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 5 | 9 | 165 | 365 | 236 | - | |
| Market Cap Growth | -48.07% | -94.33% | -54.75% | 54.35% | - | - | |
| Enterprise Value | 1 | 3 | 164 | 363 | 236 | - | |
| Last Close Price | 0.26 | 0.53 | 11.40 | 25.56 | 27.60 | - | |
| PE Ratio | - | - | - | 485.24 | 215.96 | - | |
| PS Ratio | 0.50 | 0.96 | 15.10 | 27.29 | 20.74 | - | |
| PB Ratio | 0.50 | 0.97 | 24.76 | 50.79 | 35.47 | - | |
| P/TBV Ratio | 0.85 | 0.97 | 24.76 | 50.79 | 35.47 | - | |
| P/FCF Ratio | - | - | 331.62 | 60792.57 | 1802.86 | - | |
| P/OCF Ratio | - | - | 299.07 | 39809.48 | 427.52 | - | |
| EV/Sales Ratio | 0.09 | 0.34 | 14.97 | 27.17 | 20.69 | - | |
| EV/EBITDA Ratio | - | - | - | 316.52 | 358.35 | - | |
| EV/EBIT Ratio | - | - | - | 343.88 | 415.74 | - | |
| EV/FCF Ratio | - | - | 328.74 | 60523.50 | 1798.19 | - | |
| Debt / Equity Ratio | 0.03 | 0.02 | 0.01 | 0.01 | 0.02 | 0.08 | |
| Debt / EBITDA Ratio | - | - | - | 0.07 | 0.19 | - | |
| Debt / FCF Ratio | - | - | 0.11 | 12.83 | 0.94 | - | |
| Asset Turnover | 0.82 | 0.97 | 1.19 | 1.36 | 2.01 | 0.09 | |
| Inventory Turnover | 6.42 | 7.98 | 7.74 | 8.22 | 16.34 | 6.21 | |
| Quick Ratio | 3.99 | 4.24 | 2.52 | 2.39 | 2.02 | 16.97 | |
| Current Ratio | 4.98 | 4.93 | 3.00 | 3.07 | 2.37 | 17.11 | |
| Return on Equity (ROE) | -9.87% | -32.21% | -5.14% | 10.86% | 28.11% | -18.64% | |
| Return on Assets (ROA) | -2.29% | -12.68% | -1.51% | 6.70% | 6.24% | -11.95% | |
| Return on Capital (ROIC) | -2.65% | -15.45% | -1.97% | 9.40% | 8.86% | -12.24% | |
| Earnings Yield | -19.96% | -28.08% | -0.22% | 0.21% | 0.46% | - | |
| FCF Yield | -56.19% | -15.50% | 0.30% | 0.00% | 0.06% | - | |
| Buyback Yield / Dilution | -18.10% | -10.17% | -0.99% | -66.36% | -19.16% | -30.20% | |
| Total Shareholder Return | -18.10% | -10.17% | -0.99% | -66.36% | -19.16% | -30.20% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.